33434745|t|TNF-alpha-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer's disease pathology in young Trem2R47H rats.
33434745|a|Alzheimer's disease (AD) is a neurodegenerative dementia associated with deposition of amyloid plaques and neurofibrillary tangles, formed by amyloid beta (Abeta) peptides and phosphor-tau, respectively, in the central nervous system. Approximately 2% of AD cases are due to familial AD (FAD); ~98% of cases are sporadic AD (SAD). Animal models with FAD are commonly used to study SAD pathogenesis. Because mechanisms leading to FAD and SAD may be distinct, to study SAD pathogenesis, we generated Trem2R47H knock-in rats, which carry the SAD risk factor p.R47H variant of the microglia gene triggering receptor expressed on myeloid cells 2 (TREM2). Trem2R47H rats produce human-Abeta from a humanized-App rat allele because human-Abeta is more toxic than rodent-Abeta and the pathogenic role of the p.R47H TREM2 variant has been linked to human-Abeta-clearing deficits. Using periadolescent Trem2R47H rats, we previously demonstrated that supraphysiological tumor necrosis factor-alpha (TNF-alpha) boosts glutamatergic transmission, which is excitatory, and suppresses long-term potentiation, a surrogate of learning and memory. Here, we tested the effect of the p.R47H variant on the inhibitory neurotransmitter gamma-aminobutyric acid. We report that GABAergic transmission is decreased in Trem2R47H/R47H rats. This decrease is due to acute and reversible action of TNF-alpha and is not associated with increased human-Abeta levels and AD pathology. Thus, the p.R47H variant changes the excitatory/inhibitory balance, favoring excitation. This imbalance could potentiate glutamate excitotoxicity and contribute to neuronal dysfunction, enhanced neuronal death, and neurodegeneration. Future studies will determine whether this imbalance represents an early, Abeta-independent pathway leading to dementia and may reveal the AD-modifying therapeutic potential of TNF-alpha inhibition in the central nervous system.
33434745	0	9	TNF-alpha	Gene	24835
33434745	79	98	Alzheimer's disease	Disease	MESH:D000544
33434745	118	127	Trem2R47H	CellLine	CVCL:II86
33434745	128	132	rats	Species	10116
33434745	134	153	Alzheimer's disease	Disease	MESH:D000544
33434745	155	157	AD	Disease	MESH:D000544
33434745	164	190	neurodegenerative dementia	Disease	MESH:D019636
33434745	221	228	amyloid	Disease	MESH:C000718787
33434745	241	264	neurofibrillary tangles	Disease	MESH:D055956
33434745	276	288	amyloid beta	Gene	351
33434745	290	295	Abeta	Gene	351
33434745	389	391	AD	Disease	MESH:D000544
33434745	409	420	familial AD	Disease	MESH:D000544
33434745	422	425	FAD	Disease	MESH:D000544
33434745	446	457	sporadic AD	Disease	MESH:D000544
33434745	459	462	SAD	Disease	MESH:D000544
33434745	484	487	FAD	Disease	MESH:D000544
33434745	515	518	SAD	Disease	MESH:D000544
33434745	563	566	FAD	Disease	MESH:D000544
33434745	571	574	SAD	Disease	MESH:D000544
33434745	601	604	SAD	Disease	MESH:D000544
33434745	651	655	rats	Species	10116
33434745	673	676	SAD	Disease	MESH:D000544
33434745	689	695	p.R47H	ProteinMutation	tmVar:p|SUB|R|47|H;HGVS:p.R47H;VariantGroup:0;OriginalGene:301227;CorrespondingGene:54209;CorrespondingSpecies:10116
33434745	726	774	triggering receptor expressed on myeloid cells 2	Gene	301227
33434745	776	781	TREM2	Gene	301227
33434745	794	798	rats	Species	10116
33434745	807	812	human	Species	9606
33434745	813	818	Abeta	Gene	351
33434745	840	843	rat	Species	10116
33434745	859	864	human	Species	9606
33434745	865	870	Abeta	Gene	351
33434745	890	896	rodent	Species	9989
33434745	897	902	Abeta	Gene	351
33434745	934	940	p.R47H	ProteinMutation	tmVar:p|SUB|R|47|H;HGVS:p.R47H;VariantGroup:0;OriginalGene:301227;CorrespondingGene:54209;CorrespondingSpecies:10116
33434745	941	946	TREM2	Gene	301227
33434745	974	979	human	Species	9606
33434745	980	985	Abeta	Gene	351
33434745	1026	1035	Trem2R47H	CellLine	CVCL:II86
33434745	1036	1040	rats	Species	10116
33434745	1093	1120	tumor necrosis factor-alpha	Gene	24835
33434745	1122	1131	TNF-alpha	Gene	24835
33434745	1298	1304	p.R47H	ProteinMutation	tmVar:p|SUB|R|47|H;HGVS:p.R47H;VariantGroup:0;OriginalGene:301227;CorrespondingGene:54209;CorrespondingSpecies:10116
33434745	1348	1371	gamma-aminobutyric acid	Chemical	MESH:D005680
33434745	1437	1441	R47H	ProteinMutation	tmVar:p|SUB|R|47|H;HGVS:p.R47H;VariantGroup:0;OriginalGene:301227;CorrespondingGene:54209;CorrespondingSpecies:10116
33434745	1442	1446	rats	Species	10116
33434745	1503	1512	TNF-alpha	Gene	24835
33434745	1550	1555	human	Species	9606
33434745	1556	1561	Abeta	Gene	351
33434745	1573	1575	AD	Disease	MESH:D000544
33434745	1597	1603	p.R47H	ProteinMutation	tmVar:p|SUB|R|47|H;HGVS:p.R47H;VariantGroup:0;OriginalGene:301227;CorrespondingGene:54209;CorrespondingSpecies:10116
33434745	1708	1717	glutamate	Chemical	MESH:D018698
33434745	1718	1732	excitotoxicity	Disease	
33434745	1751	1771	neuronal dysfunction	Disease	MESH:D009461
33434745	1782	1796	neuronal death	Disease	MESH:D009410
33434745	1802	1819	neurodegeneration	Disease	MESH:D019636
33434745	1895	1900	Abeta	Gene	351
33434745	1932	1940	dementia	Disease	MESH:D003704
33434745	1960	1962	AD	Disease	MESH:D000544
33434745	1998	2007	TNF-alpha	Gene	24835
33434745	Positive_Correlation	MESH:D018698	HGVS:p.R47H;CorrespondingGene:54209
33434745	Positive_Correlation	MESH:D009410	HGVS:p.R47H;CorrespondingGene:54209
33434745	Positive_Correlation	MESH:D019636	HGVS:p.R47H;CorrespondingGene:54209
33434745	Association	MESH:D000544	301227
33434745	Association	MESH:D005680	HGVS:p.R47H;CorrespondingGene:54209
33434745	Positive_Correlation	MESH:D009461	HGVS:p.R47H;CorrespondingGene:54209
33434745	Association	301227	351
33434745	Association	MESH:D003704	351
33434745	Positive_Correlation	MESH:D000544	HGVS:p.R47H;CorrespondingGene:54209
33434745	Association	MESH:D000544	24835
33434745	Association	MESH:D009410	54209
33434745	Association	MESH:D019636	54209
33434745	Association	MESH:D009461	54209
33434745	Association	MESH:D000544	54209

